Yahoo
Tokyo - Delayed Quote JPY

Japan Lifeline Co., Ltd. (7575.T)

1,629.00 -57.00 (-3.38%)
At close: November 6 at 3:30:00 PM GMT+9
Chart Range Bar
Loading chart for 7575.T
  • Previous Close 1,686.00
  • Open 1,660.00
  • Bid 1,611.00 x --
  • Ask 1,631.00 x --
  • Day's Range 1,613.00 - 1,667.00
  • 52 Week Range 1,239.00 - 1,706.00
  • Volume 207,500
  • Avg. Volume 237,710
  • Market Cap (intraday) 114.282B
  • Beta (5Y Monthly) 0.19
  • PE Ratio (TTM) 12.69
  • EPS (TTM) 128.34
  • Earnings Date (est.) Jan 29, 2027
  • Forward Dividend & Yield 56.00 (3.44%)
  • 1y Target Est 1,603.33
  • Moby Rating Neutral

Japan Lifeline Co., Ltd., a medical device company, engages in manufacturing and sale of medical device in Japan. The company's cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, disposable ECG recorder, and venous vascular closure system. Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts. In addition, the company offers gastrointestinal intervention products, including cholangioscope, biliary tube stent, papillary balloon dilatation catheter, self-expandable duodenal and colonic stent, endoscopic guidewire, and radiofrequency ablation systems; structural heart disease intervention products, such as radiofrequency wires and atrial septal defect closure devices; and embolic coil and aspiration catheter products. Japan Lifeline Co., Ltd. was incorporated in 1981 and is headquartered in Tokyo, Japan.

www.japanlifeline.com

1,304

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

7575.T
9.19%
Nikkei 225 (^N225)
14.09%

1-Year Return

7575.T
19.09%
Nikkei 225 (^N225)
12.87%

3-Year Return

7575.T
66.23%
Nikkei 225 (^N225)
75.60%

5-Year Return

7575.T
65.61%
Nikkei 225 (^N225)
93.96%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY27
Revenue 15.45B
Earnings 2.12B
Profit Margin 13.73%

Q3

FY26

Q4

FY26

Q1

FY27

Q2

FY27

0
5B
10B
15B
14.0%
15.0%
16.0%
17.0%

Analyst Insights

View More

Analyst Price Targets

1,500.00 Low
1,603.33 Average
1,629.00 Current
1,710.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.70%

  • Return on Assets (ttm)

    9.14%

  • Return on Equity (ttm)

    14.14%

  • Revenue (ttm)

    61.26B

  • Net Income Avi to Common (ttm)

    9.01B

  • Diluted EPS (ttm)

    128.34

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    11.71B

  • Total Debt/Equity (mrq)

    4.37%

  • Levered Free Cash Flow (ttm)

    2.75B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: